Assertion: actinium | /r/CapableOf | plan to exercise ad-hoc analysis
Facets:
value: based on these data
type: OTHER
Source sentences:
text: Iomab-B. Based on these data and the current status of enrollment, Actinium plans to exercise an ad-hoc analysis that could generate topline data for the primary endpoint in late 2020 and early termination of the trial if positive.